Increasing evidence has demonstrated that Ang II, via its type 1 receptor, activates a number of signaling pathways, including ROS, and transcriptional factors such as NF-κB, Ets-1, and early growth response 1 to regulate cardiac hypertrophy, inflammation, and fibrosis [47]. Here, ETS1 is linked to cardiac hypertrophy.